Literature DB >> 22996812

From sentinel cells to inflammatory culprits: cancer-associated fibroblasts in tumour-related inflammation.

Charlotte Servais1, Neta Erez.   

Abstract

Inflammation is now established as a hallmark of cancer. Cancer-associated fibroblasts (CAFs) have been established as a key component of the crosstalk between tumour cells and their microenvironment. Central to the role of CAFs in facilitating tumour growth, invasion, and metastasis is their ability to orchestrate tumour-related inflammation. CAFs and their soluble mediators provide multiple complex regulatory signals that modulate the trafficking, differentiation status, and function of inflammatory cells in the tumour microenvironment. This review focuses on pathways by which CAFs mediate tumour-promoting inflammation and modify the components of the inflammatory microenvironment that facilitate tumour initiation, progression, and metastasis.
Copyright © 2012 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22996812     DOI: 10.1002/path.4103

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  74 in total

Review 1.  Metabolic reprogramming and inflammation act in concert to control vascular remodeling in hypoxic pulmonary hypertension.

Authors:  Kurt R Stenmark; Rubin M Tuder; Karim C El Kasmi
Journal:  J Appl Physiol (1985)       Date:  2015-04-30

2.  Mesenchymal MAPKAPK2/HSP27 drives intestinal carcinogenesis.

Authors:  Ana Henriques; Vasiliki Koliaraki; George Kollias
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-29       Impact factor: 11.205

3.  Cancer-associated fibroblasts promote colorectal cancer progression by secreting CLEC3B.

Authors:  Hui-Fang Zhu; Xu-Hui Zhang; Chuan-Sha Gu; Yan Zhong; Ting Long; Yi-Dan Ma; Zhi-Yan Hu; Zu-Guo Li; Xiao-Yan Wang
Journal:  Cancer Biol Ther       Date:  2019-03-20       Impact factor: 4.742

4.  Fibroblasts form a hospitable metastatic niche in the liver.

Authors:  Neta Erez
Journal:  Nat Cell Biol       Date:  2016-04-27       Impact factor: 28.824

5.  Inflammation, wound repair, and fibrosis: reassessing the spectrum of tissue injury and resolution.

Authors:  Eric S White; Alberto R Mantovani
Journal:  J Pathol       Date:  2013-01       Impact factor: 7.996

6.  Clinical Implications of Marker Expression of Carcinoma-Associated Fibroblasts (CAFs) in Patients with Epithelial Ovarian Carcinoma After Treatment with Neoadjuvant Chemotherapy.

Authors:  Paulette Mhawech-Fauceglia; Dan Wang; Damanzoopinder Samrao; Grace Kim; Kate Lawrenson; Teodulo Meneses; Song Liu; Annie Yessaian; Tanja Pejovic
Journal:  Cancer Microenviron       Date:  2013-11-10

7.  A mediator of phosphorylated Smad2/3, evodiamine, in the reversion of TAF-induced EMT in normal colonic epithelial cells.

Authors:  Wanbin Yang; Xiuli Gong; Xiulian Wang; Chao Huang
Journal:  Invest New Drugs       Date:  2018-11-29       Impact factor: 3.850

8.  Tumor-targeting efficacy of a BF211 prodrug through hydrolysis by fibroblast activation protein-α.

Authors:  Xiao-Ping Chai; Guang-Long Sun; Yan-Fen Fang; Li-Hong Hu; Xuan Liu; Xiong-Wen Zhang
Journal:  Acta Pharmacol Sin       Date:  2017-11-09       Impact factor: 6.150

9.  Difference of TGF-β/Smads signaling pathway in epithelial-mesenchymal transition of normal colonic epithelial cells induced by tumor-associated fibroblasts and colon cancer cells.

Authors:  Xiu-Lian Wang; Chao Huang
Journal:  Mol Biol Rep       Date:  2019-03-05       Impact factor: 2.316

Review 10.  Fibroblasts, an inconspicuous but essential player in colon cancer development and progression.

Authors:  Naofumi Mukaida; Soichiro Sasaki
Journal:  World J Gastroenterol       Date:  2016-06-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.